Malady Kyle
EVP and Group CEO-VZ Business
Malady Kyle has filed 14 SEC Form 4 filings (20 transaction rows) across 2 companies, including VZ, DXCM, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, Malady Kyle is listed as EVP and Group CEO-VZ Business at VERIZON COMMUNICATIONS INC. Inside the rolling window, Malady Kyle reported no open-market purchases and 10 open-market sales totaling $525K in VZ. The largest disclosed transaction in the window is a sale of 1,100 VZ shares on Sep 15, 2026, worth $56K.
Companies traded
Other insiders at VZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$525K
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $49K | Oct 21 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $47K | Oct 14 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $50K | Oct 7 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $51K | Sep 30 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $52K | Sep 23 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $56K | Sep 16 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $55K | Sep 9 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $56K | Sep 2 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $55K | Aug 26 | SEC ↗ | |
| VZ | EVP and Group CEO-VZ Business | Sale | 1,100 | $54K | Aug 19 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 5, 2025 | DXCM | Sale | $54K |
Frequently asked questions
How many SEC Form 4 filings has Malady Kyle made?
Malady Kyle has filed 14 SEC Form 4 filings (20 transaction rows) across 2 companies, including VZ, DXCM since 2025.
Which companies does Malady Kyle trade?
Malady Kyle has filed SEC Form 4 disclosures for 2 companies, including VZ, DXCM.
When was Malady Kyle's most recent SEC Form 4 filing?
Malady Kyle's most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is Malady Kyle's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Malady Kyle is listed as EVP and Group CEO-VZ Business.
What is Malady Kyle's total buy and sell value in the current window?
Inside the rolling retention window, Malady Kyle bought $0 and sold $525K based on SEC Form 4 filings.
What was Malady Kyle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,100 VZ shares on 2026-09-15, worth $56K, per SEC Form 4 filings.